Safety and preliminary efficacy of sequential multiple ascending doses of solnatide to treat pulmonary permeability edema in patients with moderate to severe ARDS in a randomized, placebo-controlled, double-blind trial: preliminary evaluation of safety and feasibility in light of the COVID- 19 pandemic
(si apre in una nuova finestra)
Autori:
Schmid, Benedikt; Kranke, Peter; Lucas, Rudolf; Maybohm, Patrick; Zwissler, Bernhard; Frank, Susanne
Pubblicato in:
Trials, Numero 2, 2022, ISSN 1745-6215
Editore:
BioMed Central
DOI:
10.1186/s13063-022-06182-3
Conformational ensemble of the TNF-derived peptide solnatide in solution
(si apre in una nuova finestra)
Autori:
Martin-Malpartida, Pau; Arrastia-Casado, Silvia; Farrera-Sinfreu, Josep; Lucas, Rudolf; Fischer, Hendrik; Fischer, Bernhard; Eaton, Douglas C.; Tzotzos, Susan; Marcias, Maria J.
Pubblicato in:
Computational and Structural Biotechnology Journal, Numero 1, 2022, ISSN 2001-0370
Editore:
Elsevier
DOI:
10.1016/j.csbj.2022.04.031
Incidence of ARDS and outcomes in hospitalized patients with COVID-19: a global literature survey.
(si apre in una nuova finestra)
Autori:
Bernhard Fischer; Hendrik Fischer; Markus Zeitlinger; Susan Tzotzos
Pubblicato in:
Critical Care, Vol 24, Iss 1, Pp 1-4 (2020), Numero 1, 2020, ISSN 1364-8535
Editore:
Springer
DOI:
10.1186/s13054-020-03240-7
Safety and preliminary efficacy of sequential multiple ascending doses of solnatide to treat pulmonary permeability edema in patients with moderate-to-severe ARDS-a randomized, placebo-controlled, double-blind trial.
(si apre in una nuova finestra)
Autori:
Benedikt Schmid; Markus Kredel; Roman Ullrich; Katharina Krenn; Rudolf Lucas; Klaus Markstaller; Bernhard Fischer; Peter Kranke; Patrick Meybohm; Bernhard Zwißler; Sandra Frank; and the Solnatide Collaborators Group
Pubblicato in:
Trials, Numero 1, 2021, ISSN 1745-6215
Editore:
BioMed Central
DOI:
10.1186/s13063-021-05588-9
